In CAD patients, MCP-1 is mainly associated with negative effects like progression of inflammatory arteriosclerosis by activation of macrophages and monocytes, and high levels of MCP-1 are both associated with risk of CAD and inflammation [8,9,10,11]. The gene discussed is CCL2; the disease is coronary artery disorder.